
    
      At month 0, 1 and 6, 3 groups of 184 subjects received each 3 doses of herpes simplex vaccine
      lot A, B or C, respectively. The study took 14 months to complete, including screening, and 6
      visits were required. The Protocol Posting has been updated in order to comply with the FDA
      Amendment Act, Sep 2007.
    
  